(VBK) VERBIO Vereinigte - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000A0JL9W6
VBK: Biodiesel, Bioethanol, Biomethane, Biogas, Fertilizers
Verbio SE is a leading producer and distributor of bio-based fuels and finished products, operating across Germany, Europe, North America, and international markets. The company is structured into three core segments: Biodiesel, Bioethanol/Biomethane, and Other. Its product portfolio includes verbiodiesel, verbioglycerin, verbioethanol, and verbiogas, along with olefin metathesis catalysts, animal feeds such as Verbio Proti Flow and Verbio Grain Pro, phytosterols under the Sterocellent brand, and liquid fertilizer. The company also provides transport and logistics services, enhancing its operational efficiency and market reach.
Verbio SEs products serve a diverse range of industries, including fuels, cosmetics, food, medicine, pharmaceuticals, power and heat generation, and agriculture. Its customer base spans oil mills, pharmaceutical companies, energy utilities, farmers, transport operators, and LNG/CNG filling stations. This broad market presence underscores the companys strategic position in the bioenergy and specialty chemicals sectors.
Formerly known as VERBIO Vereinigte BioEnergie AG, the company rebranded as Verbio SE in December 2023, reflecting its evolution and growth. Founded in 2006 and headquartered in Leipzig, Germany, Verbio SE has established itself as a key player in the transition to sustainable energy solutions. Its commitment to innovation and renewable resources aligns with global efforts to reduce carbon emissions and dependence on fossil fuels.
From a financial perspective, Verbio SEs market capitalization stands at 754.75 million EUR, with a price-to-earnings (P/E) ratio of 38.26, indicating a premium valuation relative to its current earnings. The price-to-book (P/S) ratio of 0.39 suggests that the company is trading at a discount relative to its book value. However, the return on equity (RoE) of -3.23% raises questions about profitability and shareholder value creation. Looking ahead, the companys ability to scale its bioenergy operations and improve margins will be critical in justifying its valuation. If Verbio SE can leverage its investments in technology and market expansion to drive growth, it may position itself for long-term success in the renewable energy sector.
Additional Sources for VBK Stock
VBK Stock Overview
Market Cap in USD | 815m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception |
VBK Stock Ratings
Growth 5y | -23.2% |
Fundamental | -36.1% |
Dividend | 47.3% |
Rel. Strength | -53.7 |
Analysts | - |
Fair Price Momentum | 7.22 EUR |
Fair Price DCF | - |
VBK Dividends
Dividend Yield 12m | 1.65% |
Yield on Cost 5y | 2.40% |
Annual Growth 5y | 14.87% |
Payout Consistency | 97.5% |
VBK Growth Ratios
Growth Correlation 3m | -13% |
Growth Correlation 12m | -94.2% |
Growth Correlation 5y | -19.1% |
CAGR 5y | 1.09% |
CAGR/Max DD 5y | 0.01 |
Sharpe Ratio 12m | -0.80 |
Alpha | -68.18 |
Beta | 1.238 |
Volatility | 54.33% |
Current Volume | 66.7k |
Average Volume 20d | 173.8k |
As of April 03, 2025, the stock is trading at EUR 8.81 with a total of 66,726 shares traded.
Over the past week, the price has changed by -8.70%, over one month by +2.62%, over three months by -28.02% and over the past year by -55.51%.
Probably not. Based on ValueRay Fundamental Analyses, VERBIO Vereinigte (XETRA:VBK) is currently (April 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -36.14 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VBK as of April 2025 is 7.22. This means that VBK is currently overvalued and has a potential downside of -18.05%.
VERBIO Vereinigte has no consensus analysts rating.
According to ValueRays Forecast Model, VBK VERBIO Vereinigte will be worth about 8.1 in April 2026. The stock is currently trading at 8.81. This means that the stock has a potential downside of -8.06%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 78 | 785.7% |
Analysts Target Price | - | - |
ValueRay Target Price | 8.1 | -8.1% |